| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.605 | 0.01 | 0.605 | Nootropic | |||
| 0.574 | 0.011 | 0.574 | GABA C receptor rho-3 antagonist | 0.386 0.068 CID_105079 | ||
| 0.477 | 0.015 | 0.477 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.477 | 0.016 | 0.477 | Dyrk kinase inhibitor | |||
| 0.464 | 0.013 | 0.464 | Peroxidase inhibitor | 0.378 0.024 CID_105079 | ||
| 0.458 | 0.01 | 0.458 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.457 | 0.009 | 0.457 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.448 | 0.006 | 0.448 | Protein kinase (CK1) gamma 1 inhibitor | 0.117 0.101 CID_105079 | ||
| 0.418 | 0.016 | 0.418 | Clk dual-specificity kinase inhibitor | |||
| 0.403 | 0.017 | 0.403 | Death-associated protein kinase 3 inhibitor | 0.165 0.102 CID_105079 | ||
| 0.395 | 0.018 | 0.395 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.379 | 0.009 | 0.379 | Protein kinase (CK1) gamma inhibitor | |||
| 0.41 | 0.041 | 0.41 | Immunomodulator | |||
| 0.424 | 0.063 | 0.424 | Histamine release inhibitor | |||
| 0.405 | 0.056 | 0.405 | MAP kinase kinase 6 inhibitor | 0.231 0.216 CID_105079 | ||
| 0.359 | 0.015 | 0.359 | Protein kinase C nu inhibitor | |||
| 0.352 | 0.009 | 0.352 | Protein kinase (CK1) delta inhibitor | |||
| 0.429 | 0.089 | 0.429 | MAP kinase 1 inhibitor | 0.364 0.127 CID_105079 | ||
| 0.356 | 0.018 | 0.356 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.346 | 0.01 | 0.346 | Protein kinase (CK1) gamma 3 inhibitor | 0.163 0.076 CID_105079 | ||
| 0.386 | 0.058 | 0.386 | Angiogenesis inhibitor | 0.363 0.066 CID_105079 | ||
| 0.422 | 0.098 | 0.422 | Caspase 9 stimulant | 0.388 0.118 CID_105079 | ||
| 0.342 | 0.022 | 0.342 | CDC-like kinase 2 inhibitor | |||
| 0.33 | 0.014 | 0.33 | Protein kinase (CK1) inhibitor | |||
| 0.328 | 0.014 | 0.328 | Lck kinase inhibitor | 0.111 0.092 CID_105079 | ||
| 0.322 | 0.01 | 0.322 | Toll-Like receptor 9 antagonist | |||
| 0.316 | 0.009 | 0.316 | TRKB antagonist | |||
| 0.338 | 0.038 | 0.338 | Pyruvate kinase inhibitor | 0.2 0.081 CID_105079 | ||
| 0.325 | 0.026 | 0.325 | CDC-like kinase 4 inhibitor | |||
| 0.324 | 0.027 | 0.324 | RNA-directed DNA polymerase inhibitor | |||
| 0.333 | 0.037 | 0.333 | Tyrosine kinase inhibitor | 0.122 0.107 CID_105079 | ||
| 0.304 | 0.01 | 0.304 | CDC-like kinase 1 inhibitor | 0.114 0.102 CID_105079 | ||
| 0.334 | 0.043 | 0.334 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.339 | 0.049 | 0.339 | Hypoxia-inducible factor 1 alpha inhibitor | 0.235 0.114 CID_105079 | ||
| 0.294 | 0.012 | 0.294 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.301 | 0.021 | 0.301 | LIM domain kinase 1 inhibitor | |||
| 0.283 | 0.004 | 0.283 | Toll-Like receptor 3 antagonist | |||
| 0.286 | 0.013 | 0.286 | MAP kinase 9 inhibitor | |||
| 0.299 | 0.027 | 0.299 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.325 | 0.054 | 0.325 | Aryl hydrocarbon receptor agonist | |||
| 0.277 | 0.007 | 0.277 | Beta amyloid protein antagonist | |||
| 0.271 | 0.009 | 0.271 | MAP kinase 12 inhibitor | 0.13 0.058 CID_105079 | ||
| 0.262 | 0.011 | 0.262 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.149 0.029 CID_105079 | ||
| 0.305 | 0.055 | 0.305 | DNA damaging | 0.186 0.127 CID_105079 | ||
| 0.268 | 0.018 | 0.268 | MAP kinase kinase 3 inhibitor | 0.205 0.109 CID_105079 | ||
| 0.277 | 0.03 | 0.277 | Src kinase inhibitor | 0.201 0.054 CID_105079 | ||
| 0.255 | 0.01 | 0.255 | MAP kinase 13 inhibitor | 0.111 0.065 CID_105079 | ||
| 0.28 | 0.042 | 0.28 | MAP kinase kinase 2 inhibitor | 0.152 0.119 CID_105079 | ||
| 0.244 | 0.006 | 0.244 | Interleukin 8 antagonist | |||
| 0.367 | 0.132 | 0.367 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.24 | 0.008 | 0.24 | Protein kinase C gamma inhibitor | 0.111 0.061 CID_105079 | ||
| 0.259 | 0.029 | 0.259 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.275 | 0.044 | 0.275 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.251 | 0.024 | 0.251 | Polo-like kinase-3 inhibitor | |||
| 0.242 | 0.018 | 0.242 | Toll-Like receptor antagonist | |||
| 0.223 | 0.003 | 0.223 | Potassium channel small-conductance Ca-activated blocker | 0.046 0.029 CID_105079 | ||
| 0.228 | 0.017 | 0.228 | GABA C receptor rho-2 antagonist | 0.144 0.082 CID_105079 | ||
| 0.271 | 0.062 | 0.271 | Antiamyloidogenic | |||
| 0.214 | 0.011 | 0.214 | Raf kinase inhibitor | 0.128 0.023 CID_105079 | ||
| 0.229 | 0.026 | 0.229 | Ribosomal protein S6 kinase inhibitor | |||
| 0.209 | 0.008 | 0.327 | Platelet growth factor antagonist | 0.327 0.004 CID_105079 | CID_105079 | |
| 0.21 | 0.012 | 0.21 | Activin receptor-like kinase 4 inhibitor | 0.123 0.048 CID_105079 | ||
| 0.228 | 0.034 | 0.228 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.213 | 0.029 | 0.213 | Glycogen synthase kinase-3 inhibitor | |||
| 0.211 | 0.032 | 0.211 | Activin receptor-like kinase 2 inhibitor | |||
| 0.214 | 0.037 | 0.214 | Vascular endothelial growth factor 3 antagonist | |||
| 0.24 | 0.065 | 0.24 | Interleukin antagonist | |||
| 0.186 | 0.013 | 0.186 | Protein kinase C zeta inhibitor | |||
| 0.18 | 0.007 | 0.18 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.076 0.022 CID_105079 | ||
| 0.21 | 0.038 | 0.21 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.244 | 0.074 | 0.244 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.192 | 0.024 | 0.192 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.179 | 0.013 | 0.179 | Adenosine A2 receptor antagonist | |||
| 0.236 | 0.071 | 0.236 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.206 | 0.044 | 0.206 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.18 | 0.018 | 0.18 | TIE antagonist | 0.147 0.023 CID_105079 | ||
| 0.17 | 0.009 | 0.17 | Histamine N-methyltransferase inhibitor | 0.081 0.066 CID_105079 | ||
| 0.177 | 0.017 | 0.177 | TIE-2 antagonist | 0.146 0.023 CID_105079 | ||
| 0.164 | 0.005 | 0.164 | Potassium channel (Ca-activated) blocker | 0.08 0.018 CID_105079 | ||
| 0.248 | 0.09 | 0.248 | 5 Hydroxytryptamine release stimulant | |||
| 0.228 | 0.07 | 0.228 | EphB2 antagonist | |||
| 0.171 | 0.014 | 0.171 | Phosphodiesterase I inhibitor | 0.094 0.052 CID_105079 | ||
| 0.28 | 0.124 | 0.28 | Toll-Like receptor agonist | |||
| 0.216 | 0.06 | 0.216 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.21 | 0.054 | 0.21 | Growth factor agonist | |||
| 0.237 | 0.083 | 0.237 | Superoxide dismutase inhibitor | |||
| 0.193 | 0.038 | 0.193 | Cytokine production inhibitor | |||
| 0.186 | 0.032 | 0.186 | Glycogen synthase kinase-3 beta inhibitor | 0.092 0.089 CID_105079 | ||
| 0.214 | 0.061 | 0.214 | TRKC antagonist | |||
| 0.192 | 0.042 | 0.192 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.193 | 0.043 | 0.193 | Tyrosine-protein kinase receptor antagonist | |||
| 0.161 | 0.014 | 0.161 | Interleukin 2 antagonist | 0.106 0.073 CID_105079 | ||
| 0.166 | 0.023 | 0.166 | Insulin receptor antagonist | 0.134 0.034 CID_105079 | ||
| 0.176 | 0.033 | 0.176 | DNA intercalator | |||
| 0.212 | 0.07 | 0.212 | Nitric-oxide synthase stimulant | |||
| 0.194 | 0.053 | 0.194 | Heat shock protein 90 alpha antagonist | 0.186 0.059 CID_105079 | ||
| 0.207 | 0.065 | 0.207 | I kappa B kinase epsilon inhibitor | |||
| 0.155 | 0.017 | 0.155 | Pim-3 kinase inhibitor | |||
| 0.15 | 0.012 | 0.15 | Phenylalanine 4-hydroxylase inhibitor | 0.101 0.025 CID_105079 | ||
| 0.203 | 0.065 | 0.203 | Histone acetyltransferase inhibitor | |||
| 0.151 | 0.014 | 0.151 | Raf kinase B inhibitor | 0.096 0.024 CID_105079 | ||
| 0.161 | 0.026 | 0.161 | MAP kinase 8 inhibitor | |||
| 0.149 | 0.015 | 0.149 | Adenosine A2a receptor antagonist | |||
| 0.173 | 0.039 | 0.173 | MAP kinase kinase inhibitor | 0.152 0.05 CID_105079 | ||
| 0.147 | 0.015 | 0.147 | Raf kinase C inhibitor | |||
| 0.181 | 0.048 | 0.181 | Heat shock protein 90 antagonist | 0.144 0.08 CID_105079 | ||
| 0.152 | 0.021 | 0.152 | GABA C receptor rho-1 antagonist | |||
| 0.172 | 0.041 | 0.204 | MAP kinase 3 inhibitor | 0.204 0.022 CID_105079 | CID_105079 | |
| 0.138 | 0.008 | 0.138 | Toll-Like receptor 7 antagonist | |||
| 0.146 | 0.018 | 0.146 | MAP kinase 11 inhibitor | |||
| 0.146 | 0.021 | 0.146 | CDC-like kinase 3 inhibitor | 0.106 0.067 CID_105079 | ||
| 0.157 | 0.032 | 0.157 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.171 | 0.047 | 0.171 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.152 | 0.029 | 0.152 | DNA repair enzyme inhibitor | |||
| 0.155 | 0.035 | 0.155 | Heat shock protein 70 antagonist | |||
| 0.217 | 0.098 | 0.217 | DNA synthesis inhibitor | |||
| 0.129 | 0.011 | 0.129 | Granulocyte macrophage colony stimulating factor agonist | 0.08 0.077 CID_105079 | ||
| 0.173 | 0.057 | 0.173 | Cyclin-dependent kinase 3 inhibitor | 0.144 0.11 CID_105079 | ||
| 0.177 | 0.061 | 0.177 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.16 | 0.044 | 0.16 | TRKA antagonist | |||
| 0.15 | 0.035 | 0.15 | MAP kinase kinase kinase inhibitor | |||
| 0.149 | 0.036 | 0.149 | Polo-like kinase-4 inhibitor | |||
| 0.166 | 0.055 | 0.166 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.125 | 0.014 | 0.125 | CDC7 inhibitor | |||
| 0.129 | 0.018 | 0.129 | Bromodomain-containing protein 2 inhibitor | |||
| 0.128 | 0.018 | 0.128 | Adenosine A1 receptor antagonist | |||
| 0.16 | 0.051 | 0.16 | Cyclin-dependent kinase inhibitor | |||
| 0.127 | 0.018 | 0.127 | Glutamate release inhibitor | |||
| 0.124 | 0.016 | 0.124 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.151 | 0.044 | 0.151 | Platelet activating factor antagonist | 0.141 0.05 CID_105079 | ||
| 0.135 | 0.029 | 0.135 | Acetylcholine release stimulant | |||
| 0.165 | 0.06 | 0.165 | Growth factor antagonist | |||
| 0.118 | 0.014 | 0.118 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.127 | 0.024 | 0.127 | Telomerase inhibitor | |||
| 0.155 | 0.053 | 0.155 | Vascular endothelial growth factor antagonist | |||
| 0.12 | 0.019 | 0.12 | Cyclin A2 inhibitor | |||
| 0.142 | 0.041 | 0.154 | Platelet activating factor beta antagonist | 0.154 0.036 CID_105079 | CID_105079 | |
| 0.107 | 0.007 | 0.107 | Toll-Like receptor 8 antagonist | |||
| 0.116 | 0.017 | 0.116 | Protein kinase B beta inhibitor | |||
| 0.117 | 0.019 | 0.117 | mTOR complex 2 inhibitor | |||
| 0.107 | 0.01 | 0.107 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.082 0.034 CID_105079 | ||
| 0.172 | 0.075 | 0.172 | Tumour necrosis factor antagonist | 0.149 0.102 CID_105079 | ||
| 0.128 | 0.032 | 0.128 | Phosphodiesterase 7B inhibitor | |||
| 0.124 | 0.028 | 0.124 | Polo-like kinase-1 inhibitor | |||
| 0.157 | 0.061 | 0.157 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.105 | 0.01 | 0.105 | Adenosine A2b receptor antagonist | |||
| 0.121 | 0.027 | 0.121 | MAP kinase 14 inhibitor | |||
| 0.181 | 0.087 | 0.181 | Focal adhesion kinase 2 inhibitor | |||
| 0.106 | 0.013 | 0.106 | 5 Hydroxytryptamine 3 agonist | 0.058 0.052 CID_105079 | ||
| 0.139 | 0.046 | 0.139 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.107 | 0.015 | 0.107 | Secretase beta inhibitor | |||
| 0.12 | 0.028 | 0.12 | Porphobilinogen synthase inhibitor | |||
| 0.215 | 0.126 | 0.215 | Gastrin inhibitor | |||
| 0.148 | 0.059 | 0.148 | Phosphodiesterase inhibitor | |||
| 0.188 | 0.1 | 0.188 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.243 | 0.155 | 0.243 | Calcium channel activator | |||
| 0.108 | 0.02 | 0.108 | Cyclin A inhibitor | |||
| 0.132 | 0.046 | 0.132 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.11 | 0.025 | 0.11 | CDK1/cyclin B1 inhibitor | |||
| 0.128 | 0.045 | 0.128 | GABA C receptor antagonist | 0.103 0.073 CID_105079 | ||
| 0.104 | 0.022 | 0.104 | Polo-like kinase-2 inhibitor | |||
| 0.123 | 0.04 | 0.123 | CDK2/cyclin A inhibitor | |||
| 0.121 | 0.038 | 0.121 | Folate antagonist | |||
| 0.13 | 0.049 | 0.13 | GABA receptor agonist | |||
| 0.111 | 0.03 | 0.111 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.135 | 0.054 | 0.135 | Vascular endothelial growth factor 2 antagonist | |||
| 0.094 | 0.014 | 0.094 | Glutamate (mGluR7) antagonist | |||
| 0.102 | 0.022 | 0.102 | Transforming growth factor beta 3 antagonist | |||
| 0.084 | 0.005 | 0.084 | Cytokine production stimulant | 0.048 0.034 CID_105079 | ||
| 0.134 | 0.054 | 0.134 | Aurora-B kinase inhibitor | |||
| 0.213 | 0.137 | 0.229 | Insulysin inhibitor | 0.229 0.118 CID_105079 | CID_105079 | |
| 0.088 | 0.013 | 0.088 | Phosphodiesterase 1A inhibitor | |||
| 0.108 | 0.034 | 0.108 | AXL receptor tyrosine kinase inhibitor | |||
| 0.117 | 0.045 | 0.117 | Gastric antisecretory | |||
| 0.126 | 0.054 | 0.126 | Cystathionine beta-synthase inhibitor | |||
| 0.095 | 0.024 | 0.095 | Transforming growth factor antagonist | |||
| 0.138 | 0.067 | 0.138 | Interleukin 1 antagonist | |||
| 0.091 | 0.02 | 0.091 | Potassium channel (ATP-sensitive) blocker | |||
| 0.174 | 0.103 | 0.174 | Platelet aggregation inhibitor | |||
| 0.091 | 0.022 | 0.091 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.089 | 0.019 | 0.089 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.158 | 0.089 | 0.19 | Death-associated protein kinase 2 inhibitor | 0.19 0.043 CID_105079 | CID_105079 | |
| 0.206 | 0.14 | 0.206 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.173 | 0.106 | 0.173 | Neurotrophic factor enhancer | |||
| 0.111 | 0.044 | 0.111 | MAP kinase kinase 1 inhibitor | |||
| 0.096 | 0.032 | 0.096 | Interferon agonist | |||
| 0.095 | 0.031 | 0.095 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.094 | 0.03 | 0.094 | Adenosine A3 receptor antagonist | |||
| 0.083 | 0.019 | 0.083 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.082 | 0.02 | 0.082 | Phosphodiesterase 4C inhibitor | 0.056 0.038 CID_105079 | ||
| 0.089 | 0.027 | 0.089 | MAP kinase kinase 7 inhibitor | |||
| 0.072 | 0.011 | 0.072 | Histamine H4 receptor antagonist | |||
| 0.086 | 0.026 | 0.086 | MAP kinase 7 inhibitor | |||
| 0.097 | 0.037 | 0.097 | CYP2A6 inhibitor | |||
| 0.089 | 0.029 | 0.089 | I kappa B kinase 1 inhibitor | |||
| 0.097 | 0.039 | 0.097 | Hematopoietic | |||
| 0.061 | 0.003 | 0.061 | Toll-Like receptor 8 agonist | |||
| 0.081 | 0.023 | 0.081 | Interferon inducer | |||
| 0.081 | 0.024 | 0.081 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.115 | 0.057 | 0.115 | Ferrochelatase inhibitor | |||
| 0.14 | 0.083 | 0.14 | Cytidine deaminase inhibitor | |||
| 0.098 | 0.041 | 0.098 | MAP-kinase-activated kinase inhibitor | |||
| 0.092 | 0.037 | 0.092 | Protein kinase B gamma inhibitor | |||
| 0.118 | 0.063 | 0.118 | Protein kinase (CK2) alpha inhibitor | |||
| 0.087 | 0.033 | 0.087 | Benzodiazepine agonist | |||
| 0.1 | 0.046 | 0.1 | Insulin growth factor antagonist | |||
| 0.115 | 0.062 | 0.115 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.103 | 0.05 | 0.103 | CDK/cyclin complex inhibitor | |||
| 0.105 | 0.053 | 0.105 | Pim-1 kinase inhibitor | |||
| 0.081 | 0.029 | 0.081 | Protein kinase C beta inhibitor | |||
| 0.098 | 0.047 | 0.098 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.094 | 0.043 | 0.094 | Myeloperoxidase inhibitor | |||
| 0.105 | 0.054 | 0.105 | Fibroblast growth factor 1 antagonist | 0.091 0.065 CID_105079 | ||
| 0.075 | 0.024 | 0.075 | Phosphodiesterase 1C inhibitor | |||
| 0.072 | 0.021 | 0.072 | mTOR inhibitor | |||
| 0.096 | 0.045 | 0.096 | Insulin like growth factor 1 antagonist | |||
| 0.07 | 0.019 | 0.07 | Histamine agonist | |||
| 0.087 | 0.038 | 0.087 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.073 | 0.025 | 0.073 | Cyclin D1 inhibitor | |||
| 0.138 | 0.09 | 0.138 | MAP kinase kinase 4 inhibitor | |||
| 0.084 | 0.036 | 0.084 | MAP3K7 inhibitor | |||
| 0.068 | 0.02 | 0.068 | Transforming growth factor beta 1 antagonist | |||
| 0.071 | 0.024 | 0.071 | Pim-2 kinase inhibitor | |||
| 0.07 | 0.024 | 0.07 | Phosphodiesterase 4A inhibitor | |||
| 0.067 | 0.022 | 0.079 | AMPA receptor antagonist | 0.079 0.017 CID_105079 | CID_105079 | |
| 0.094 | 0.049 | 0.094 | Protein kinase A inhibitor | |||
| 0.073 | 0.028 | 0.073 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.119 | 0.076 | 0.135 | c-Src kinase inhibitor | 0.135 0.064 CID_105079 | CID_105079 | |
| 0.187 | 0.145 | 0.187 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.086 | 0.045 | 0.086 | MAP kinase 10 inhibitor | |||
| 0.052 | 0.011 | 0.052 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.048 | 0.008 | 0.048 | ATR kinase inhibitor | |||
| 0.102 | 0.062 | 0.102 | Protein kinase (CK2) inhibitor | |||
| 0.07 | 0.031 | 0.07 | CDK9/cyclin T1 inhibitor | |||
| 0.089 | 0.05 | 0.089 | GABA A receptor agonist | |||
| 0.076 | 0.037 | 0.076 | Fibroblast growth factor 2 antagonist | |||
| 0.062 | 0.024 | 0.062 | Aconitate hydratase inhibitor | |||
| 0.066 | 0.028 | 0.066 | Cyclin A1 inhibitor | |||
| 0.065 | 0.027 | 0.065 | Phosphodiesterase II inhibitor | |||
| 0.059 | 0.021 | 0.059 | Phosphodiesterase X inhibitor | |||
| 0.059 | 0.021 | 0.059 | Phosphodiesterase 10A inhibitor | |||
| 0.065 | 0.028 | 0.065 | GABA A receptor antagonist | |||
| 0.068 | 0.031 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.096 | 0.061 | 0.096 | Protein kinase C mu inhibitor | |||
| 0.063 | 0.029 | 0.063 | Bromodomain-containing protein 4 inhibitor | |||
| 0.094 | 0.06 | 0.094 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.068 | 0.034 | 0.068 | Cyclin B1 inhibitor | |||
| 0.149 | 0.115 | 0.149 | Anesthetic general | |||
| 0.036 | 0.003 | 0.036 | Granulocyte colony stimulating factor receptor agonist | 0.026 0.004 CID_105079 | ||
| 0.062 | 0.031 | 0.062 | GABA receptor antagonist | |||
| 0.057 | 0.026 | 0.057 | Phosphodiesterase 2A inhibitor | |||
| 0.044 | 0.013 | 0.044 | ATM kinase inhibitor | |||
| 0.072 | 0.041 | 0.072 | Protein kinase C alpha inhibitor | |||
| 0.118 | 0.088 | 0.118 | Interleukin 4 antagonist | |||
| 0.052 | 0.022 | 0.052 | Benzodiazepine inverse agonist | |||
| 0.081 | 0.051 | 0.081 | ErbB-4 antagonist | |||
| 0.158 | 0.128 | 0.158 | Potassium channel blocker | |||
| 0.091 | 0.062 | 0.091 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.066 | 0.038 | 0.066 | Transcription factor RelA inhibitor | |||
| 0.057 | 0.028 | 0.057 | H+/K+-transporting ATPase inhibitor | |||
| 0.072 | 0.044 | 0.072 | p38 MAP kinase inhibitor | |||
| 0.173 | 0.146 | 0.173 | Interleukin agonist | |||
| 0.104 | 0.077 | 0.104 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.077 | 0.049 | 0.077 | Phosphodiesterase 4D inhibitor | |||
| 0.158 | 0.131 | 0.158 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.049 | 0.023 | 0.049 | Histamine H2 receptor agonist | |||
| 0.072 | 0.046 | 0.072 | Protein kinase B alpha inhibitor | |||
| 0.081 | 0.056 | 0.081 | Phosphodiesterase 11A inhibitor | |||
| 0.081 | 0.056 | 0.081 | Phosphodiesterase XI inhibitor | |||
| 0.047 | 0.022 | 0.047 | Dihydrofolate reductase inhibitor | |||
| 0.038 | 0.014 | 0.038 | Plasmepsin I inhibitor | |||
| 0.167 | 0.144 | 0.167 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.038 | 0.015 | 0.038 | Protein kinase (CK2) beta inhibitor | |||
| 0.084 | 0.061 | 0.084 | Antineoplastic alkaloid | |||
| 0.046 | 0.023 | 0.046 | Cyclin D3 inhibitor | 0.035 0.032 CID_105079 | ||
| 0.065 | 0.042 | 0.065 | CDK1/cyclin B inhibitor | |||
| 0.046 | 0.024 | 0.046 | Histamine H1 receptor agonist | |||
| 0.099 | 0.077 | 0.099 | 5 Hydroxytryptamine 3A agonist | |||
| 0.035 | 0.013 | 0.035 | CDK4/cyclin D3 inhibitor | |||
| 0.06 | 0.04 | 0.06 | Phosphatidylinositol kinase inhibitor | |||
| 0.027 | 0.008 | 0.027 | Histamine H4 receptor agonist | |||
| 0.053 | 0.034 | 0.053 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.051 | 0.032 | 0.051 | Bromodomain-containing protein 3 inhibitor | |||
| 0.089 | 0.07 | 0.148 | Platelet activating factor alpha antagonist | 0.148 0.031 CID_105079 | CID_105079 | |
| 0.05 | 0.033 | 0.05 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.048 | 0.031 | 0.048 | Thymidylate synthase inhibitor | |||
| 0.035 | 0.019 | 0.035 | Transforming growth factor beta 2 antagonist | |||
| 0.028 | 0.012 | 0.028 | Acid ceramidase inhibitor | |||
| 0.061 | 0.046 | 0.061 | Prolactin release inhibitor | |||
| 0.059 | 0.044 | 0.059 | Alpha 2 adrenoreceptor agonist | |||
| 0.067 | 0.052 | 0.067 | Syk tyrosine kinase inhibitor | |||
| 0.066 | 0.051 | 0.066 | MAP kinase kinase 8 inhibitor | |||
| 0.021 | 0.006 | 0.021 | Prokineticin receptor 1 antagonist | |||
| 0.063 | 0.048 | 0.063 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.089 | 0.075 | 0.089 | Aurora-A kinase inhibitor | |||
| 0.035 | 0.021 | 0.035 | Glutamate (mGluR4) agonist | |||
| 0.036 | 0.024 | 0.036 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.021 | 0.009 | 0.021 | Cyclin T1 inhibitor | |||
| 0.088 | 0.077 | 0.088 | Electrolyte absorption antagonist | |||
| 0.082 | 0.072 | 0.082 | Hepatocyte growth factor antagonist | |||
| 0.146 | 0.135 | 0.146 | HERG channel blocker | |||
| 0.053 | 0.042 | 0.053 | Cyclin B inhibitor | |||
| 0.082 | 0.073 | 0.082 | Protein kinase C delta inhibitor | |||
| 0.058 | 0.049 | 0.058 | Phosphodiesterase VII inhibitor | |||
| 0.034 | 0.025 | 0.034 | Adenosine uptake inhibitor | |||
| 0.072 | 0.062 | 0.072 | Fibroblast growth factor 3 antagonist | |||
| 0.152 | 0.143 | 0.152 | MAP kinase kinase 5 inhibitor | |||
| 0.039 | 0.03 | 0.039 | CDK5/p25 inhibitor | |||
| 0.053 | 0.044 | 0.053 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.056 | 0.047 | 0.056 | Heat shock protein 90 beta antagonist | |||
| 0.052 | 0.044 | 0.052 | Alcohol oxidase inhibitor | |||
| 0.046 | 0.039 | 0.046 | Dopamine beta hydroxylase inhibitor | |||
| 0.05 | 0.043 | 0.05 | Protein kinase C eta inhibitor | |||
| 0.244 | 0.237 | 0.244 | 5 Hydroxytryptamine release inhibitor | |||
| 0.04 | 0.033 | 0.04 | Glutamate (mGluR group III) agonist | |||
| 0.082 | 0.075 | 0.082 | Antihistaminic | |||
| 0.029 | 0.024 | 0.029 | Potassium channel small-conductance Ca-activated activator | |||
| 0.043 | 0.037 | 0.043 | CDK7/cyclin H inhibitor | |||
| 0.052 | 0.047 | 0.052 | MAP kinase kinase 9 inhibitor | |||
| 0.051 | 0.046 | 0.051 | Cyclin B2 inhibitor | |||
| 0.087 | 0.083 | 0.087 | GABA C receptor agonist | |||
| 0.05 | 0.046 | 0.05 | Bruton tyrosine kinase inhibitor | |||
| 0.094 | 0.09 | 0.094 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.034 | 0.03 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.049 | 0.046 | 0.049 | Lysine-specific demethylase 1A inhibitor | |||
| 0.073 | 0.071 | 0.073 | I kappa B kinase inhibitor | |||
| 0.046 | 0.043 | 0.046 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.013 | 0.011 | 0.013 | 5 Lipoxygenase activating protein inhibitor | |||
| 0.099 | 0.098 | 0.099 | RET inhibitor | |||
| 0.038 | 0.036 | 0.038 | Plasmepsin II inhibitor | |||
| 0.049 | 0.048 | 0.049 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.089 | 0.088 | 0.089 | mTOR complex 1 inhibitor | |||
| 0.093 | 0.131 | 0.106 | Transcription factor STAT6 inhibitor | 0.106 0.09 CID_105079 | CID_105079 | |
| 0.113 | 0.193 | 0.139 | ATPase inhibitor | 0.139 0.122 CID_105079 | CID_105079 | |
| 0.092 | 0.253 | 0.28 | Tumour necrosis factor alpha release inhibitor | 0.28 0.061 CID_105079 | CID_105079 | |
| 0.006 | 0.211 | 0.035 | Histone deacetylase 1 inhibitor | 0.035 0.014 CID_105079 | CID_105079 | |
| 0.005 | 0.317 | 0.049 | Histone deacetylase class IIb inhibitor | 0.049 0.011 CID_105079 | CID_105079 | |
| 0.005 | 0.32 | 0.048 | Histone deacetylase 6 inhibitor | 0.048 0.011 CID_105079 | CID_105079 | |
| 0.005 | 0.337 | 0.038 | Histone deacetylase 2 inhibitor | 0.038 0.019 CID_105079 | CID_105079 | |
| 0.005 | 0.38 | 0.059 | Histone deacetylase class II inhibitor | 0.059 0.01 CID_105079 | CID_105079 | |
| 0.013 | 0.404 | 0.037 | ADAM10 endopeptidase inhibitor | 0.037 0.018 CID_105079 | CID_105079 | |
| 0.004 | 0.416 | 0.03 | Histone deacetylase 10 inhibitor | 0.03 0.021 CID_105079 | CID_105079 | |
| 0.004 | 0.475 | 0.054 | Histone deacetylase 5 inhibitor | 0.054 0.015 CID_105079 | CID_105079 | |
| 0.006 | 0.481 | 0.032 | Histone deacetylase class IV inhibitor | 0.032 0.021 CID_105079 | CID_105079 | |
| 0.006 | 0.481 | 0.032 | Histone deacetylase 11 inhibitor | 0.032 0.021 CID_105079 | CID_105079 | |
| 0.004 | 0.57 | 0.04 | Histone deacetylase class IIa inhibitor | 0.04 0.017 CID_105079 | CID_105079 | |
| 0.004 | 0.589 | 0.029 | Histone deacetylase 4 inhibitor | 0.029 0.024 CID_105079 | CID_105079 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |